BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).

BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).

The affected product is vulnerable due to an insufficient session expiration. An unauthorized physical breach of a BD Synapsys workstation would be negligible due to the sequence of events that must occur in a specific order, however successful exploitation could lead to modification of ePHI, PHI, or PII. The result could cause delayed or incorrect treatment.CVE-2022-30277 has been assigned to this vulnerability. A CVSS v3 base score of 5.7 has been calculated; the CVSS vector string is (AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N).